Login / Signup

[Efficiency evaluation of the Neuromidin in the treatment of pain of the patients with discogenic lumbosacral radiculopathy: results of a multicenter post-registration prospective open comparative trial].

Andrey DanilovF I DevlikamovaOlga KurushinaYulia KarakulovaD Yu ButkoA A Smirnova
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)
Administration of Neuromidine 15 mg/1 ml once a day intramuscularly for 10 days followed by 20 mg 3 times a day for 8 weeks has an effective analgesic effect as adjuvant therapy in patients with discogenic lumbosacral radiculopathy. The inclusion of Neuromidine in the complex treatment of patients with pain syndrome in discogenic radiculopathy is superior in efficacy to standard drug therapy.
Keyphrases
  • randomized controlled trial
  • emergency department
  • stem cells
  • spinal cord injury
  • spinal cord
  • replacement therapy
  • phase iii
  • gestational age